Holter-guided identification of premature ventricular contractions susceptible to suppression by β-blockers

American Heart Journal

Volumn 131, Issue 3, 1996, Pages 508-515

  Pitzalis, Maria Vittoria ^a   Mastropasqua, Filippo ^b   Massari, Francesco ^b   Totaro, Paolo ^b   Di Maggio, Marinella ^a   Rizzon, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL;

ADULT; AGED; ARTICLE; BRADYCARDIA; FEMALE; HEART CYCLE; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VAGUS REFLEX;

EID: 0029866365     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90529-3     Document Type: Article

References (36)

1. Winkle RA, Gradman AH, Fitzgerald JW, Bell PA. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine. Am J Cardiol 1978;42:473-80.
2. Woosley RL, Kernhauser D, Smith R, Reale S, Higgins SB, Nies AS, Shand DG, Dates JA. Suppression of chronic ventricular arrhythmias with propranolol. Circulation 1979;60:819-27.
3. Lui HK, Lee G, Dhurandhar R, Hungate EJ, Laddu A, Dietrich P, Mason DT. Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study. AM HEART J 1983;105:722-6.
4. de Soyza N. Acebutolol for premature ventricular contractions: shortand long-term effects. AM HEART J 1985;109:1205-10.
5. Morganroth J, Duchin KL. Effectiveness of low-dose nadolol for ventricular arrhythmias. Am J Cardiol 1986;58:273-8.
6. Gibson D, Sowton E. The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis 1969;12:16-39.
7. Olsson G, Wikstrand J, Warnold I, Manger Cats V, McBoyle D, Herlitz J, Sonnenblick E. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992;13:28-32.
8. Olsson G, Tuomiletho J, Berglund G, Elmfeldt D, Warnold I, Barber H, Eliasson K, Jastrup B, Karatzas N, Leer J, Marchetta F, Ragnarsson J, Robitaille NM, Valkova L, Wesseling H, Wilkstrand J. Primary prevention of sudden cardiovascular death in hypertensive patients: mortality results from the MAPHY study. Am J Hypertens 1991;4:151-8.
9. Coumel P, Escoubet B, Attuel P. Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol. AM HEART J 1984;108:1098-1108.
10. Coumel P, Zimmermann M, Funck-Brentano C. Exercise test: arrhythmogenic or antiarrhythmic? Rate dependency vs adrenergic-dependency of tachyarrhythmias. Eur Heart J 1987;8(suppl D):7-15.
11. Winkle RA. The relationship between ventricular ectopic beat frequency and heart rate. Circulation 1982;66(2):439-46.
12. Funck-Brentano C, Coumel P, Lorente P, Maison-Blanche P, Slama R. Rate dependence of ventricular extrasystoles: computer identification and quantitative analysis. Cardiovasc Res 1988;22:101-7.
13. Coumel P. Rate dependence and adrenergic dependence of arrhythmias. Am J Cardiol 1989;64:41j-45j.
14. Facchini M, De Ferrari GM, Bonazzi O, Weiss T, Schwartz PJ. Effect of reflex vagal activation on frequency of ventricular premature complexes. Am J Cardiol 1991;68:349-54.
15. Pitzalis MV, Maino GN, Massari F, Mastropasqua F, Rizzon P. Incidence and reproducibility of different patterns of relationship between sinus cycle length and premature ventricular beats [Abstract]. Eur Heart J 1991;12(suppl):354.
16. Pitzalis MV, Mastropasqua F, Massari F, Di Maggio M, Totaro P, Rizzon P. Analysis of rate dependent premature ventricular complexes [Abstract]. Eur Heart J 1994;15:1060.
17. Coumel P, Leclercq JF, Escoubet B. Beta-blockers: use for arrhythmias. Eur Heart J 1987;8(suppl A):41-52.
18. Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drag. AM HEART J 1980;99:124-8.
19. Gibson JK, Gelband H, Bassett AL. Direct and beta adrenergic blocking action of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium. J Pharmacol Exp Ther 1977;202:702-10.
20. Evans DB, Peschka MT, Lee RJ, Laffan RJ. Antiarrhythmic action of nadolol, a β-adrenergic receptor blocking agent. Eur J Pharmacol 1976; 35:17-27.
21. Mastropasqua F, Pitzalis MV, Massari F, Totaro P, Rizzon P. Correlation between sleep suppression phenomenon and beta-blocker effect on premature ventricular complexes [Abstract]. Circulation 1993;88(suppl II):447.
22. Han J, DeTraglia J, Millet D. Moe GK. Incidence of ectopic beats as a function of basic rate in the ventricle. AM HEART J 1966;72:632-9.
23. Chadda KD, Banka VS. Helfant RH. Rate dependent ventricular ectopia following acute coronary occlusion: the concept of an optimal antiarrhythmic heart rate. Circulation 1974;49:654-8.
24. Vassalle M, Greenspan K, Hoffman BF. An analysis of arrhythmias induced by intact dogs. Circ Res 1963;13:132-48.
25. Langendorf R, Pick A, Winternitz M. Mechanism of intermittent ventricular bigeminy. Circulation 1955;11:422-30.
26. Weiss T, Lattin GM, Engelman K. Vagally mediated suppression of premature ventricular contractions in man. AM HEART J 1975;89:700-7.
27. Zipes DP, Knoebel SB. Rapid rate-dependent ventricular ectopy. Adverse responses to atropine-induced rate increase. Chest 1972; 62:255-8.
28. Scrutinio D, Mastropasqua F, Mangini SG, LaGioia R, Zanna D, Chiddo A, Rizzon P. Transient transmural myocardial ischemia: relationship between heart rate changes and ventricular arrhythmias. In: Cosin J, Bayes de Luna AJ, Garcia Civera R, Cabades A, eds. Cardiac arrhythmias. Diagnosis and treatment. Oxford: Pergamon Press, 1988:491-502.
29. Coumel P. Multiplicity of arrhythmogenic factors. A plea for combined therapies. Int J Cardiol 1983;4:477-80.
30. Coumel P, Attuel P, Slama R, Bouvrain Y. A quantitative evaluation of arrhythmias by computerising prolonged ECG tracings. Arch Mal Coeur 1978;71:300-1.
31. Morganroth J, Borland M, Chao G. Application of a frequency definition of ventricular proarrhythmia. Am J Cardiol 1987;59:97-9.
32. Brodsky MA, Allen BJ, Luckett CR, Capparelli EV, Wolff LJ, Henry WL. Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmias. AM HEART J 1989;118:272-80.
33. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The "Sicilian Gambit." A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991;84:1831-51 and simultaneously in Eur Heart J 1991;12:1112-31.
34. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The "Sicilian Gambit." A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991;84:1831-51 and simultaneously in Eur Heart J 1991;12:1112-31.
35. Wit AL, Rosen MR. Afterdepolarizations and triggered activity. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system. New York: Raven Press, 1986:1449-90.
36. Cranefield PF, Aronson RS. The causes, characteristics and consequences of early after depolarizations. In: Cranefield PF, Aronson RS, eds. Cardiac arrhythmias: the role of triggered activity and other mechanism. New York: Futura Publishing, 1988:431-79.